Remove 2012 Remove Intellectual Property Law Remove Patent Application
article thumbnail

Special 301 Report 2023: Reflections from Public Health Perspective

SpicyIP

However, Section 3(d) has been an issue for the big pharmaceutical companies, as an obstruction to get secondary patents on trivial variations because it blocks patents from becoming “evergreen” and gives opportunity to generic pharmaceutical firms to produce biosimilar drugs and sell them at a much lower price.

Reporting 137
article thumbnail

In re Couvaras, No. 2022-1489 (Fed. Cir. June 14, 2023)

Intellectual Property Law Blog

Patent Application 15/131,442 (the “’442 Patent”) with claims directed to a method of increasing prostacyclin release in systemic blood vessels of a human to improve vasodilation and reduce hypertension. Background John L. Couvaras filed U.S. to note that “[a]rguments raised only in footnotes [] are waived.” Otsuka Pharm.

Art 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

UCB, Inc. v. Actavis Laboratories UT, Inc. No. 2021-1924, (Fed. Cir. Apr. 12, 2023)

Intellectual Property Law Blog

In 2014, UCB sued Actavis for infringement of the Muller patents. UCB prevailed in the lawsuit, and was awarded an injunction against Actavis until March 2021, when one of the Muller patents expires. In 2018, UCB filed a new patent application (the “’589 patent”, priority date 2009) covering a reformulation of Neupro.

Art 130
article thumbnail

SpicyIP Weekly Review (February 17 – February 23)

SpicyIP

Highlights of the Week Cheroots to Cheers or Bringing IP Conversations to Wider Audiences: A SpicyIP Initiative for Vernacular Dissemination ‘De-code Indian Intellectual Property Law’ – For who? The deadline to file the comments is February 28.

article thumbnail

SpicyIP Weekly Review (February 17 – February 23)

SpicyIP

Highlights of the Week Cheroots to Cheers or Bringing IP Conversations to Wider Audiences: A SpicyIP Initiative for Vernacular Dissemination ‘De-code Indian Intellectual Property Law’ – For who? The deadline to file the comments is February 28.

article thumbnail

The Role of Intellectual Property Rights in India’s Startup Ecosystem: A Pathway to Innovation and Growth.

IIPRD

Also, the Government has recently made an Amendment to the Patent Rule i.e. Indian Patent (Amendment) Rules, 2024 which aims to rationalize the patent application process and reduce the burden of the compilation and accelerate actions. Trademarks and Registered Trademarks, Control of Corp Diseases, 2012.

article thumbnail

Raising the Bar Has Not Reduced the Patent Acceptance Rate in Australia

LexBlog IP

Some people may have anticipated that, in raising the standard of inventive step and introducing stricter requirements for enablement and support of claims, the RtB reforms would result in fewer applications being accepted. I was not one of those people, and I expect that neither were most other patent attorneys.